InVivoMAb Anti-SARS-CoV-2 RBD Antibody (S309)

SKU: VK565010

Size:100ug

Description:S309 is a monoclonal antibody that targets the spike (S) glycoprotein of SARS-CoV-2. It potently neutralizes SARS-CoV-2 and SARS-CoV by binding a conserved glycan-containing epitope in the receptor-binding domain, without blocking receptor attachment. S309 has demonstrated strong neutralization alone and in antibody cocktails, offering potential for prophylaxis and post-exposure therapy.

Host species:Human

Species reactivity:SARS-CoV-2(2019-nCoV), SARS-CoV

Form:Liquid

Storage buffer:0.01M PBS, pH 7.4.

Purity:>95% as determined by SDS-PAGE.

Clonality:Monoclonal

Isotype:IgG1, kappa

Applications:ELISA, Neutralization

Target:Spike glycoprotein, S glycoprotein, E2, Peplomer protein, RBD, Spike protein S1, S, Receptor-Binding Domain

Purification:Protein A/G purified from cell culture supernatant.

Endotoxin level:Please contact us for this information.

Accession:P0DTC2

Stability and Storage:Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID:S309

Product Usage Information:

Predicted molecular weight:

Note:For research use only. Not suitable for clinical or therapeutic use.